73 related articles for article (PubMed ID: 29133704)
21. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
22. Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.
de la Fuente MI; Young RJ; Rubel J; Rosenblum M; Tisnado J; Briggs S; Arevalo-Perez J; Cross JR; Campos C; Straley K; Zhu D; Dong C; Thomas A; Omuro AA; Nolan CP; Pentsova E; Kaley TJ; Oh JH; Noeske R; Maher E; Choi C; Gutin PH; Holodny AI; Yen K; DeAngelis LM; Mellinghoff IK; Thakur SB
Neuro Oncol; 2016 Feb; 18(2):283-90. PubMed ID: 26691210
[TBL] [Abstract][Full Text] [Related]
23. Molecular subtype impacts surgical resection in low-grade gliomas: A Chinese Glioma Genome Atlas database analysis.
Hou Z; Zhang K; Liu X; Fang S; Li L; Wang Y; Jiang T
Cancer Lett; 2021 Dec; 522():14-21. PubMed ID: 34517083
[TBL] [Abstract][Full Text] [Related]
24. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
[TBL] [Abstract][Full Text] [Related]
25. IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
27. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Patil V; Mahalingam K
Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
[TBL] [Abstract][Full Text] [Related]
28. Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study.
Hempel JM; Brendle C; Bender B; Bier G; Skardelly M; Gepfner-Tuma I; Eckert F; Ernemann U; Schittenhelm J
J Neurooncol; 2018 Sep; 139(2):373-381. PubMed ID: 29667086
[TBL] [Abstract][Full Text] [Related]
29. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.
Zhao J; Wang YL; Li XB; Hu MS; Li ZH; Song YK; Wang JY; Tian YS; Liu DW; Yan X; Jiang L; Yang ZY; Chu JP
J Neurooncol; 2019 Jan; 141(1):195-203. PubMed ID: 30414095
[TBL] [Abstract][Full Text] [Related]
31. Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.
Mazurowski MA; Clark K; Czarnek NM; Shamsesfandabadi P; Peters KB; Saha A
J Neurooncol; 2017 May; 133(1):27-35. PubMed ID: 28470431
[TBL] [Abstract][Full Text] [Related]
32. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance.
Claus EB; Horlacher A; Hsu L; Schwartz RB; Dello-Iacono D; Talos F; Jolesz FA; Black PM
Cancer; 2005 Mar; 103(6):1227-33. PubMed ID: 15690327
[TBL] [Abstract][Full Text] [Related]
33. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.
Laws ER; Parney IF; Huang W; Anderson F; Morris AM; Asher A; Lillehei KO; Bernstein M; Brem H; Sloan A; Berger MS; Chang S;
J Neurosurg; 2003 Sep; 99(3):467-73. PubMed ID: 12959431
[TBL] [Abstract][Full Text] [Related]
34. Karnofsky Performance Scale and Neurological Assessment of Neuro-Oncology Scale as Early Predictor in Glioma.
Gunawan PY; Islam AA; July J; Patellongi I; Nasrum M; Aninditha T
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3387-3392. PubMed ID: 33247700
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis.
Bauman G; Lote K; Larson D; Stalpers L; Leighton C; Fisher B; Wara W; MacDonald D; Stitt L; Cairncross JG
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):923-9. PubMed ID: 10571199
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
Wahl M; Phillips JJ; Molinaro AM; Lin Y; Perry A; Haas-Kogan DA; Costello JF; Dayal M; Butowski N; Clarke JL; Prados M; Nelson S; Berger MS; Chang SM
Neuro Oncol; 2017 Feb; 19(2):242-251. PubMed ID: 27571885
[TBL] [Abstract][Full Text] [Related]
37. Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion.
Brendle C; Hempel JM; Schittenhelm J; Skardelly M; Tabatabai G; Bender B; Ernemann U; Klose U
Clin Neuroradiol; 2018 Sep; 28(3):421-428. PubMed ID: 28488024
[TBL] [Abstract][Full Text] [Related]
38. Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
Jain R; Narang J; Griffith B; Bagher-Ebadian H; Scarpace L; Mikkelsen T; Littenberg B; Schultz LR
Acad Radiol; 2013 Apr; 20(4):478-85. PubMed ID: 23498990
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.
Catalán-Uribarrena G; Bilbao-Barandica G; Pomposo-Gaztelu I; Undabeitia-Huertas J; Ruiz de Gopegui-Ruiz E; Galbarriatu-Gutiérrez L; Canales-Llantada M; Aurrecoechea-Obieta J; Igartua-Azkune A; Carbayo-Lozano G
Acta Neurochir (Wien); 2012 Feb; 154(2):211-22; discussion 222. PubMed ID: 22002506
[TBL] [Abstract][Full Text] [Related]
40. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.
Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T
Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
